DZ2200A1 - Compositions pour un traitement une fois par jour des maladies ayant pour mediateur la 2-cyclooxygenase. - Google Patents
Compositions pour un traitement une fois par jour des maladies ayant pour mediateur la 2-cyclooxygenase.Info
- Publication number
- DZ2200A1 DZ2200A1 DZ970087A DZ970087A DZ2200A1 DZ 2200 A1 DZ2200 A1 DZ 2200A1 DZ 970087 A DZ970087 A DZ 970087A DZ 970087 A DZ970087 A DZ 970087A DZ 2200 A1 DZ2200 A1 DZ 2200A1
- Authority
- DZ
- Algeria
- Prior art keywords
- cyclooxygenase
- compositions
- once daily
- diseases mediated
- daily treatment
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1787896P | 1996-05-17 | 1996-05-17 | |
GBGB9612063.9A GB9612063D0 (en) | 1996-06-10 | 1996-06-10 | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ2200A1 true DZ2200A1 (fr) | 2004-06-20 |
Family
ID=26309472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ970087A DZ2200A1 (fr) | 1996-05-17 | 1997-05-14 | Compositions pour un traitement une fois par jour des maladies ayant pour mediateur la 2-cyclooxygenase. |
Country Status (29)
Country | Link |
---|---|
US (1) | US6063811A (fr) |
EP (1) | EP0910368A1 (fr) |
JP (1) | JPH11512754A (fr) |
KR (1) | KR100373622B1 (fr) |
CN (1) | CN1140267C (fr) |
AR (1) | AR012014A1 (fr) |
AU (1) | AU3004997A (fr) |
BG (1) | BG103000A (fr) |
BR (1) | BR9709097A (fr) |
CA (1) | CA2254061C (fr) |
CO (1) | CO5050370A1 (fr) |
CZ (1) | CZ291463B6 (fr) |
DZ (1) | DZ2200A1 (fr) |
EA (1) | EA001596B1 (fr) |
EE (1) | EE03746B1 (fr) |
HK (1) | HK1021623A1 (fr) |
HR (1) | HRP970262A2 (fr) |
HU (1) | HUP9902889A3 (fr) |
ID (1) | ID16921A (fr) |
IL (1) | IL126899A (fr) |
IS (1) | IS4891A (fr) |
MY (1) | MY116201A (fr) |
NO (1) | NO985342L (fr) |
NZ (1) | NZ332670A (fr) |
PE (1) | PE66998A1 (fr) |
PL (1) | PL188649B1 (fr) |
SK (1) | SK284330B6 (fr) |
TR (1) | TR199802345T2 (fr) |
WO (1) | WO1997044028A1 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
WO1999045913A1 (fr) * | 1998-03-13 | 1999-09-16 | Merck & Co., Inc. | Therapie associee destinee au syndrome ischemique coronarien aigu ainsi qu'a des troubles connexes |
SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
CO5190664A1 (es) | 1999-06-30 | 2002-08-29 | Pfizer Prod Inc | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 |
GB9920558D0 (en) * | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
NZ519466A (en) * | 1999-12-22 | 2004-02-27 | Pharmacia Corp | Sustained-release formulation of a cyclooxygenase-2 inhibitor |
PL206268B1 (pl) | 2000-06-13 | 2010-07-30 | Wyethwyeth | Kompozycja przeciwbólowa i/lub przeciwzapalna oraz jej zastosowanie |
CN1638739A (zh) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | 治疗成瘾性障碍的化合物 |
ATE329583T1 (de) * | 2000-08-18 | 2006-07-15 | Pharmacia Corp | Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib |
AU2001285334A1 (en) * | 2000-08-29 | 2002-03-13 | Peter Van Patten | Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid |
PE20020351A1 (es) * | 2000-09-11 | 2002-06-14 | Novartis Ag | Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2 |
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
EP1423114A4 (fr) * | 2001-05-04 | 2006-05-17 | Merck & Co Inc | Procede et compositions pour le traitement des migraines |
PE20030323A1 (es) * | 2001-08-31 | 2003-05-12 | Novartis Ag | Composicion farmaceutica |
GEP20063856B (en) * | 2001-09-26 | 2006-06-26 | Pharmacia Corp | Organoleptically acceptable intraorally disintegrating compositions |
CA2462881A1 (fr) * | 2001-10-10 | 2003-04-17 | Pharmacia Corporation | Compositions de valdecoxib a desintegration intra-orale preparees a l'aide d'un procede de sechage par pulverisation |
AU2003227039B2 (en) * | 2002-03-07 | 2007-04-19 | Novartis Ag | Pharmaceutical compositions |
ES2213485B1 (es) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | Derivados de la 2-fenilpiran-4-ona. |
ES2214129B1 (es) * | 2003-02-13 | 2005-12-01 | Almirall Prodesfarma, S.A. | 3-fenilfuran-2-onas. |
ES2275218T3 (es) | 2003-05-07 | 2007-06-01 | Osteologix A/S | Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos. |
TR200301552A1 (tr) * | 2003-09-18 | 2005-10-21 | Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Rofekoksib' in yeni oral farmakolojik formülasyonları. |
CN101626787A (zh) * | 2007-01-19 | 2010-01-13 | 马林克罗特公司 | 诊断的和治疗的环氧合酶-2结合配体 |
CN113660934A (zh) | 2018-11-21 | 2021-11-16 | 特默罗制药股份有限公司 | 罗非昔布的纯化形式、制备方法和用途 |
WO2020210341A1 (fr) * | 2019-04-09 | 2020-10-15 | Tremeau Pharmaceuticals, Inc. | Traitement de fièvres hémorragiques virales avec des médicaments anti-inflammatoires non stéroïdiens sélectifs de cox-2 |
US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
HUT74986A (en) * | 1994-01-10 | 1997-03-28 | Merck Frosst Canada Inc | Phenyl heterocycles as cox-2 inhibitors, pharmaceutical preparations containing them, and use of them |
-
1997
- 1997-05-13 TR TR1998/02345T patent/TR199802345T2/xx unknown
- 1997-05-13 BR BR9709097A patent/BR9709097A/pt not_active IP Right Cessation
- 1997-05-13 IL IL12689997A patent/IL126899A/en not_active IP Right Cessation
- 1997-05-13 EP EP97924688A patent/EP0910368A1/fr not_active Withdrawn
- 1997-05-13 JP JP9542486A patent/JPH11512754A/ja active Pending
- 1997-05-13 HU HU9902889A patent/HUP9902889A3/hu unknown
- 1997-05-13 SK SK1567-98A patent/SK284330B6/sk unknown
- 1997-05-13 WO PCT/US1997/008041 patent/WO1997044028A1/fr not_active Application Discontinuation
- 1997-05-13 CZ CZ19983738A patent/CZ291463B6/cs not_active IP Right Cessation
- 1997-05-13 EA EA199801017A patent/EA001596B1/ru not_active IP Right Cessation
- 1997-05-13 KR KR10-1998-0709239A patent/KR100373622B1/ko not_active IP Right Cessation
- 1997-05-13 CN CNB971963150A patent/CN1140267C/zh not_active Expired - Fee Related
- 1997-05-13 CA CA002254061A patent/CA2254061C/fr not_active Expired - Fee Related
- 1997-05-13 EE EE9800393A patent/EE03746B1/xx not_active IP Right Cessation
- 1997-05-13 NZ NZ332670A patent/NZ332670A/xx unknown
- 1997-05-13 AU AU30049/97A patent/AU3004997A/en not_active Abandoned
- 1997-05-13 US US09/180,647 patent/US6063811A/en not_active Expired - Lifetime
- 1997-05-14 AR ARP970102021A patent/AR012014A1/es unknown
- 1997-05-14 DZ DZ970087A patent/DZ2200A1/fr active
- 1997-05-15 PE PE1997000379A patent/PE66998A1/es not_active Application Discontinuation
- 1997-05-16 MY MYPI97002138A patent/MY116201A/en unknown
- 1997-05-16 HR HR9612063.9A patent/HRP970262A2/xx not_active Application Discontinuation
- 1997-05-16 ID IDP971640A patent/ID16921A/id unknown
- 1997-05-16 CO CO97026568A patent/CO5050370A1/es unknown
-
1998
- 1998-11-10 IS IS4891A patent/IS4891A/is unknown
- 1998-11-16 NO NO985342A patent/NO985342L/no not_active Application Discontinuation
- 1998-12-08 BG BG103000A patent/BG103000A/xx unknown
-
1999
- 1999-01-11 PL PL97329940A patent/PL188649B1/pl not_active IP Right Cessation
-
2000
- 2000-02-02 HK HK00100645A patent/HK1021623A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2200A1 (fr) | Compositions pour un traitement une fois par jour des maladies ayant pour mediateur la 2-cyclooxygenase. | |
FR12C0077I2 (fr) | Composition pour le traitement des condylomes génitaux | |
FR15C0070I2 (fr) | Composes heteroaromatiques azotes pour le traitement des maladies de cancer | |
EA200800375A1 (ru) | Соединения и способы ингибирования экспрессии vcam-1 | |
MA26992A1 (fr) | Derives de phenethanolamine pour le traitement des maladies respiratoires | |
MA28289A1 (fr) | Immunoglobulines | |
MA25823A1 (fr) | Compositions pour le traitement de l'eau. | |
DE69630479D1 (de) | Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten | |
EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
TNSN94105A1 (fr) | Composes sulfonamides tricycliques utiles pour l'inhibition de la fonction proteine g et pour le traitement des maladies proliferatives | |
TNSN97145A1 (fr) | Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant | |
OA09478A (fr) | "Utilisation de la N-myristoyl-(S)-phénylalaine pour l'obtention de médicaments destinés au traitement des maladies faisant intervenir la myristoylation". | |
ATE286895T1 (de) | Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten | |
DZ3014A1 (fr) | Médicaments pour le traitement de l'hypertension. | |
MA26950A1 (fr) | Nouveaux retinoides pour le traitement de l'emphyseme | |
DE69519577D1 (de) | Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes | |
ATE201992T1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
DE69622472D1 (de) | Behandlung von Krankheiten durch Induktion von BEF-1 Transkriptionsfaktor | |
FR2758465B1 (fr) | Composition pour le traitement de l'amiante | |
DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
MA25852A1 (fr) | Methode pour le traitement de l'inflammation. | |
DZ3225A1 (fr) | Methode et compositions pour le traitement des maladies pulmonaires |